ScoreWhy is Xiamen Amoytop Biotech Co. Ltd. ?
1
The company has declared Positive results for the last 18 consecutive quarters
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- NET SALES(Q) Highest at CNY 1,216.02 MM
- OPERATING PROFIT(Q) Highest at CNY 472.2 MM
2
With ROE of 34.50%, it has a fair valuation with a 12.11 Price to Book Value
- Over the past year, while the stock has generated a return of -9.14%, its profits have risen by 45.3% ; the PEG ratio of the company is 0.8
- At the current price, the company has a high dividend yield of 0.8
3
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 22.49% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -9.14% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Xiamen Amoytop Biotech Co. Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Xiamen Amoytop Biotech Co. Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Xiamen Amoytop Biotech Co. Ltd.
-24.87%
1.17
33.59%
China Shanghai Composite
19.22%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.97%
EBIT Growth (5y)
51.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
1.09
Tax Ratio
10.37%
Dividend Payout Ratio
24.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
40.89%
ROE (avg)
22.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
6.43
EV to EBIT
18.82
EV to EBITDA
17.10
EV to Capital Employed
8.28
EV to Sales
5.87
PEG Ratio
1.56
Dividend Yield
1.08%
ROCE (Latest)
43.98%
ROE (Latest)
27.84%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 657.02 MM
NET SALES(HY)
At CNY 2,013.81 MM has Grown at 31.42%
CASH AND EQV(HY)
Highest at CNY 2,102.29 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 0.95 times
-25What is not working for the Company
INTEREST(HY)
At CNY 1.35 MM has Grown at 532.39%
INTEREST COVERAGE RATIO(Q)
Lowest at 27,657.17
ROCE(HY)
Lowest at 31.78%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.99 times
NET SALES(Q)
At CNY 797.79 MM has Fallen at -13.57%
OPERATING PROFIT(Q)
Lowest at CNY 189.95 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 23.81 %
PRE-TAX PROFIT(Q)
Lowest at CNY 179.04 MM
NET PROFIT(Q)
Lowest at CNY 164.49 MM
EPS(Q)
Lowest at CNY 0.4
Here's what is working for Xiamen Amoytop Biotech Co. Ltd.
Operating Cash Flow
Highest at CNY 657.02 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Cash and Eqv
Highest at CNY 2,102.29 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 0.95 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Xiamen Amoytop Biotech Co. Ltd.
Interest
At CNY 1.35 MM has Grown at 532.39%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 27,657.17 and Fallen
In each period in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Net Sales
At CNY 797.79 MM has Fallen at -13.57%
over average net sales of the previous four periods of CNY 923.03 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Debtors Turnover Ratio
Lowest at 3.99 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Operating Profit
Lowest at CNY 189.95 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 23.81 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 179.04 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 179.04 MM has Fallen at -38.89%
over average net sales of the previous four periods of CNY 292.98 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 164.49 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Net Profit
At CNY 164.49 MM has Fallen at -36.01%
over average net sales of the previous four periods of CNY 257.07 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.4
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
